- Home
- Aesthetic gynaecology
- Darkened vulva
- Lightening the intimate area
Lightening the intimate area: what is safe and what to avoid
Demand for products to lighten the intimate area is growing, but genital skin is thin and sensitive. See which cause to treat first, what may help with guidance and what to avoid.
Quando existir, entra aqui e também no cartão da página do blog.
In this article
Demand for treatments to lighten the intimate area has been growing, fuelled by social media and advertising. Before going ahead, it is important to know three things: darker genital skin is normal; the skin in this area is thinner and more sensitive than facial skin; and many products sold to “whiten” are ineffective, irritating or even banned.
Three ideas to remember.
Fica por baixo do resumo, se existir uma segunda foto.
Before lightening: what is the cause?
| Cause | Main approach |
|---|---|
| Physiological pigmentation | Information; aesthetic treatment only if desired, with modest expectations |
| Friction (thighs, clothing) | Reduce friction; barriers; then mild depigmenting agents |
| Post-inflammatory hyperpigmentation | Treat the inflammation (folliculitis, dermatitis) and wait; then depigmenting agents |
| Acanthosis nigricans | Assess and treat insulin resistance |
| New isolated spot | Medical examination before any treatment (Murzaku et al., 2014) |
What may help, with guidance
- Mild depigmenting agents on the outer skin of the groin and labia majora, such as azelaic acid, niacinamide, topical tranexamic acid or kojic acid, introduced gradually to test tolerance.
- Superficial peels performed by a doctor, in selected cases, with mild agents and many precautions.
- Laser or intense pulsed light, in very selected cases; the risk of darkening further is real, especially in brown skin.
The evidence specific to the genital area is limited: most of the data come from melasma on the face (Desai, 2014; Rajaratnam et al., 2010). Results are gradual and require maintenance.
What to avoid
- Products containing mercury, which are banned in the European Union and toxic (Regulation (EC) No 1223/2009).
- Potent corticosteroids used without medical supervision, which thin the skin and cause stretch marks and infections.
- Hydroquinone without a prescription: in the European Union it is banned in cosmetics for the skin; it can only be used as a prescribed medicine, and generally not on the mucosa.
- Products bought online without clear labelling, often adulterated.
- Lemon, baking soda, hydrogen peroxide and other “home hacks”, which irritate and may darken the skin further.
- Any product on the mucosa (inner labia minora, entrance of the vagina) without medical advice.
When to see a doctor
If in doubt, call the SNS 24 line (808 24 24 24). In an emergency, call 112.
At Luxmed Clinic
At Luxmed Clinic, we start by identifying the cause of the pigmentation. When it makes sense to treat, we explain the options, the evidence, the risks and the maintenance, without promises of “whitening”.
Talk to us
The assessment is a conversation, with no obligation. Tell us what concerns you and our team will reply.
This article is for information only and does not replace a medical assessment. Results vary from person to person.
Frequently asked questions
Is it possible to make the intimate area the same colour as the rest of the skin?
In most cases, no. The realistic aim is to reduce spots and even out the tone.
Are the results permanent?
No. Without controlling the cause (friction, hair removal, hormones), the pigmentation tends to come back.
Can I use the cream I use for dark spots on my face?
Only with guidance: many are too irritating for genital skin.
Scientific references 4
- Regulamento (CE) n.º 1223/2009 do Parlamento Europeu e do Conselho, relativo aos produtos cosméticos (Anexos II e III). Lei
- Desai SR. Hyperpigmentation therapy: a review. J Clin Aesthet Dermatol. 2014;7(8):13-17. Artigo
- Rajaratnam R, Halpern J, Salim A, Emmett C. Interventions for melasma. Cochrane Database Syst Rev. 2010;(7):CD003583. Revisão Cochrane
- Murzaku EC, Penn LA, Hale CS, Pomeranz MK, Polsky D. Vulvar nevi, melanosis, and melanoma: an epidemiologic, clinical, and histopathologic review. J Am Acad Dermatol. 2014;71(6):1241-1249. Artigo
Keep exploring

